Humana Inc. (HUM) Financial Statements
Historical financial data — 41 statements covering FY2016–FY2025
Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Me...
Humana Inc.'s revenue increased 10.1% year over year, from $117.76B to $129.66B.
Net income decreased 1.6% over the same period, from $1.21B to $1.19B.
Over the 9-year period from FY2016 to FY2025, revenue grew by 138% in total.
Total debt increased by 5.5% to $12.37B.
The debt-to-equity ratio stands at 0.70, indicating a moderate leverage profile.
Operating cash flow declined 68.9% to $921.0M.
Humana Inc. maintains a moderate net profit margin of 0.9%.
Recent Financial Statements
| Period | Revenue | Net Income | Gross Profit | EBIT | Op. Cash Flow | Total Assets | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| Q3 FY2023 | $79.91B+49.4% | $3.03B | N/A | $4.36B | $11.12B | $55.91B | $11.73B | $16.95B |
| Q1 FY2024 | $29.61B-62.9% | $741.0M | N/A | $1.24B | $423.0M | $50.09B | $13.21B | $16.13B |
| Q2 FY2024 | $59.15B+99.8% | $1.42B | N/A | $2.38B | $1.64B | $50.09B | $12.89B | $16.67B |
| Q3 FY2024 | $88.55B+49.7% | $1.90B | N/A | $3.10B | $3.49B | $50.01B | $13.02B | $17.57B |
| Q1 FY2025 | $32.11B-63.7% | $1.24B | N/A | $2.01B | $331.0M | $50.93B | $13.31B | $17.75B |
| Q2 FY2025 | $64.50B+100.9% | $1.79B | N/A | $3.11B | $1.60B | $50.36B | $12.59B | $18.23B |
| Q3 FY2025 | $97.15B+50.6% | $1.98B | N/A | $3.51B | $2.57B | $49.72B | $12.61B | $18.52B |
| Q1 FY2026 | $39.65B-59.2% | $1.19B | N/A | $1.75B | $1.25B | $55.28B | $13.99B | $18.58B |
Balance Sheet Summary (Latest Period)
Total Assets
$48.91B
Total Liabilities
$31.17B
Total Equity
$17.66B
Cash & Equivalents
$19.90B
Total Debt
$12.37B
Current Assets
$32.73B
Current Liabilities
$16.35B
Retained Earnings
$29.07B